BioNTech SE (0A3M) Income Statement
BioNTech SE Income Statement
Last quarter (Q2 2026), BioNTech SE's total revenue was $105.60M, a decrease of 59.51% from the same quarter last year. In Q2, BioNTech SE's net income was $-820.80M. See BioNTech SE’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 2.76B | $ 2.75B | $ 3.82B | $ 17.31B | $ 18.98B | |
| $ 2.14B | $ 2.21B | $ 3.22B | $ 14.32B | $ 16.07B | |
| $ 2.76B | $ 3.52B | $ 2.53B | $ 1.67B | $ 781.40M | |
| Depreciation and Amortization | $ 367.69M | $ 298.00M | $ 183.40M | $ 123.30M | $ 75.20M |
| $ -628.00M | $ -367.10M | $ 1.38B | $ 13.10B | $ 15.00B | |
| $ -623.87M | $ -1.31B | $ 690.40M | $ 12.64B | $ 15.28B | |
| $ -385.46M | $ 636.60M | $ 495.70M | $ 311.40M | $ -237.40M | |
| $ -1.01B | $ -677.70M | $ 1.19B | $ 12.95B | $ 15.05B | |
| $ -1.09B | $ -665.30M | $ 930.30M | $ 9.43B | $ 10.29B | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.51 | $ -2.77 | $ 3.87 | $ 38.08 | $ 43.87 |
| Diluted EPS | $ -4.51 | $ -2.77 | $ 3.83 | $ 37.09 | $ 41.21 |
| Weighted Average Shares Outstanding | 241.70M | 240.40M | 240.60M | 243.30M | 244.00M |
| Weighted Average Shares Outstanding (Diluted) | 241.70M | 240.40M | 242.70M | 249.80M | 259.70M |
Currency in EUR
